Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Securities Purchase Agreement On July 29, 2025, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a
. The Shares and the Warrant and the issuance of the Warrant Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”)
Financial Statements and Exhibits. (d) Exhibits . The following documents are filed as exhibits to this current report on Form 8-K or incorporated by reference